Adriana Milillo Naraine, MD

Breast Medical Oncology

Memorial Division of Breast Medical Oncology

12235 Pines Boulevard
Pembroke Pines, FL 33026



Get Directions

About Me

I am a breast medical oncologist at Memorial Cancer Institute, where I diagnose and manage care for patients with all stages of breast cancer.


I trained at Montefiore Medical Center and Albert Einstein College of Medicine in New York, and during my fellowship, I felt an extraordinary connection with my breast cancer patients. Before joining Memorial in 2016, I was an attending physician and lead research physician at the Comprehensive Cancer Center at Lincoln Medical and Mental Health Center in Bronx, New York, where I also served as an Institutional Board Review Member.


When working with patients and their families, I always explain their specific type of cancer, the stage and available options so they can participate actively in decision-making. I want my patients to feel comfortable, secure, and confident in their care. Family support and engagement are also vital, and we involve patients and their loved ones every step of the way.


Our resources here at Memorial for patients and physicians are above and beyond. They enable us to deliver the best treatments and care for breast cancer and offer patients the support and care they need throughout the process.



Universidad De Carabobo, 2001


Jacobi Medical Center, 2004


Jacobi Medical Center, 2006


Montefiore Medical Center, 2009, Oncology and Hematology


American Board of Internal Medicine-Hematology
American Board of Internal Medicine-Internal Medicine
American Board of Internal Medicine-Medical Oncology

Awards, Achievements, and More


Cancer Center Lincoln Hospital (2012–2015)

  • Multiple Cooperative Research Group Clinical Trials including SWOG Protocol S0017, S1202 and NSABP Protocol B-43

Clinical Trials as Sub-Investigator at Mercy Hospital (2009–2012)

  • Open-label, randomized, phase 3 study of Inotuzumab Ozogamicin administered in combination with Rituximab compared to defined investigator’s choice therapy in subjects with relapsed or refractory CD22 positive Non-Hodgkin Lymphoma who are not candidates for high-dose chemotherapy
  • Randomized phase 4 study comparing two intravenous Temsirolimus (TEMSR) regimens in subjects with relapsed, refractory Mantle Cell Lymphoma
  • Randomized phase 2 no comparative study of the efficacy of PF-04691502 and PF-05212384 in patients with recurrent endometrial cancer
  • Collection of plasma specimen for subjects receiving Docetaxel/Paclitaxel therapy for advanced solid tumors
  • Dietary intervention and exercise therapy in Breast Cancer patients
  • Phase 3, double blind, placebo controlled study of the effects of GTX-024 on muscle wasting in patients with Non Small Cell Lung Cancer (NSCLC) on first line chemotherapy containing platinum based agent plus Taxane
  • Phase 3, double blind, placebo controlled study of the effects of GTX-024 on muscle wasting in patients with NSCLC on first line chemotherapy containing platinum based agent plus non-Taxane based agent

Basic science experience in new targeted therapies in B-cell Lymphoma. (July 2004–September 2005)

  • Leandro Cerchietti MD, Adriana Milillo MD, Ari Melnik MD
  • Albert Einstein College of Medicine. Cancer Center, Molecular Biology Laboratory

Is a recent episode of Diverticulitis an acceptable indication for colonoscopy? (August 2003–March 2004)

  • Pascale Anglade MD, Adriana Milillo MD, Daniel Gelrud MD
  • Albert Eisntein College of Medicine. Jacobi Medical Center. Gastrointestinal Department
  • Poster presented at Digestive Disease Week (DDW), May 2004, New Orleans.
  • Published in Gastrointestinal Endoscopy, Volume 59 Number 5, April 2004, W1598.
  • ASGE Meeting, May 18–21, 2004

Risk assessment for developing eating disorders in teenagers (March 1999–October 2001)

  • Adriana Milillo MD, Silvia Morales MD
  • University of Carabobo. Public Health Department. Valencia, Venezuela
  • Awarded by the Carabobo College of Physicians, March 2002

Role of emotions in the development of multiple intelligence (July 1996–November 1997)

  • Adriana Milillo, Maria Miranda, Lorenzo Montilla
  • University of Carabobo, Valencia, Venezuela
  • Presented at the Annual Meeting of the Venezuelan Medical Association for the Advanceof Science, November 1997, Valencia, Venezuela
  • Published in the Venezuelan Association for the Advance of Science Journal. Volume II, Page 442, November 1997

Professional Organizations

  • American Society of Clinical Oncology
  • American Society of Hematology


  • Outstanding Resident Award, Albert Einstein College of Medicine, New York, June 2006
  • Teaching Award, Albert Einstein College of Medicine, New York, June 2005
  • ASH (America Society of Hematology) Trainee Award, 2005
  • Summa Cum Laude, University of Carabobo, Valencia, Venezuela, December 2001
  • Outstanding Teaching Assistant Award, Biochemistry Department, University of Carabobo, Valencia, Venezuela, 1998-2001